Log In
BCIQ
Print this Print this
 

CPC-201

  Manage Alerts
Collapse Summary General Information
Company Allergan plc
DescriptionCombination of Aricept donepezil, a reversible acetylcholinesterase (AChE) inhibitor, and solifenacin, a peripherally acting cholinergic blocker
Molecular Target Acetylcholinesterase (AChE)
Mechanism of ActionAcetylcholinesterase (AChE) inhibitor
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentPhase II
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD); Treat Alzheimer's disease (AD) type dementia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

$125.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

11/22/2016

Undisclosed

$125.0M

Undisclosed

Get a free BioCentury trial today